Drug information for DEXMEDETOMIDINE HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100MCG
Tentative Approval
DEXMEDETOMIDINE HYDROCHLORIDE
Dexmedetomidine
CARACO
202126
INJECTABLE; INJECTION
100MCG (base) /mL
Tentative Approval
DEXMEDETOMIDINE HYDROCHLORIDE
Dexmedetomidine
AKORN INC
202585
INJECTABLE; INJECTION
100MCG
Tentative Approval
DEXMEDETOMIDINE HYDROCHLORIDE
Dexmedetomidine
SANDOZ
91465
2011-03-16 Letter
Drug Adverse Effects information for DEXMEDETOMIDINE HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
PS
HYPERTENSION
HYPOTENSION
1
PS
HYPERTENSION
POLYURIA
1
PS
HYPERTENSION
TACHYCARDIA
1
PS
MAINTENANCE OF ANAESTHESIA
HYPOTENSION
1
PS
MAINTENANCE OF ANAESTHESIA
POLYURIA
1
PS
MAINTENANCE OF ANAESTHESIA
TACHYCARDIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTENSION
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
POLYURIA
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
TACHYCARDIA
2
PS
SEDATION
ATRIOVENTRICULAR BLOCK SECOND DEGREE
1
PS
SEDATION
BLISTER
1
PS
SEDATION
CARDIAC FAILURE
1
PS
SEDATION
ERYTHEMA
1
PS
SEDATION
INJECTION SITE EXTRAVASATION
1
PS
SEDATION
LOSS OF CONSCIOUSNESS
1
PS
SEDATION
SWELLING
1
PS
SEDATION
VENTRICULAR FIBRILLATION
1
PS
SEDATION
VENTRICULAR TACHYCARDIA
1
SS
ANAESTHESIA
APNOEA
15
SS
ANAESTHESIA
DRUG INTERACTION
15
SS
ANAESTHESIA
RESPIRATORY DEPRESSION
15
SS
CONSTIPATION
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
1
SS
EPIDURAL ANAESTHESIA
BRADYCARDIA
6
SS
EPIDURAL ANAESTHESIA
HYPOTENSION
6
SS
EPIDURAL ANAESTHESIA
INJECTION SITE PAIN
6
SS
EPIDURAL ANAESTHESIA
RESPIRATORY DEPRESSION
6
SS
HYPOTONIA
APNOEA
3
SS
HYPOTONIA
DRUG INTERACTION
3
SS
HYPOTONIA
RESPIRATORY DEPRESSION
3
SS
INDUCTION OF ANAESTHESIA
DRUG INTERACTION
4
SS
INDUCTION OF ANAESTHESIA
POLYURIA
4
SS
INFECTION
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
1
SS
INSOMNIA
APNOEA
6
SS
INSOMNIA
DRUG INTERACTION
6
SS
INSOMNIA
RESPIRATORY DEPRESSION
6
SS
MAINTENANCE OF ANAESTHESIA
DRUG INTERACTION
4
SS
MAINTENANCE OF ANAESTHESIA
POLYURIA
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
APNOEA
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY DEPRESSION
3
SS
PYREXIA
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
1
SS
SEDATION
APNOEA
3
SS
SEDATION
DRUG INTERACTION
3
SS
SEDATION
RESPIRATORY DEPRESSION
3
C
ANTIBIOTIC PROPHYLAXIS
ABDOMINAL DISCOMFORT
2
C
ANTIBIOTIC PROPHYLAXIS
BLOOD GLUCOSE INCREASED
2
C
ANTIBIOTIC PROPHYLAXIS
DIARRHOEA
2
C
ANTIBIOTIC PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
ANTIBIOTIC PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
ANTIBIOTIC PROPHYLAXIS
EPISTAXIS
2
C
ANTIBIOTIC PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ANTIBIOTIC PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
ANTIBIOTIC PROPHYLAXIS
ORAL HERPES
2
C
ANTIBIOTIC PROPHYLAXIS
PLEURISY
2
C
ANTIBIOTIC PROPHYLAXIS
PNEUMONIA
2
C
ANTIBIOTIC PROPHYLAXIS
PRURITUS
2
C
ANTIBIOTIC PROPHYLAXIS
PYREXIA
2
C
ANTIBIOTIC PROPHYLAXIS
RENAL FAILURE ACUTE
2
C
ANTIBIOTIC PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
2
C
ANTIBIOTIC PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
2
C
ANTIBIOTIC PROPHYLAXIS
VOMITING
2
C
ANTIBIOTIC PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
2
C
ANTIFUNGAL PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
ANTIFUNGAL PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
ANTIFUNGAL PROPHYLAXIS
DIARRHOEA
1
C
ANTIFUNGAL PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
ANTIFUNGAL PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
ANTIFUNGAL PROPHYLAXIS
EPISTAXIS
1
C
ANTIFUNGAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
ANTIFUNGAL PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
ANTIFUNGAL PROPHYLAXIS
ORAL HERPES
1
C
ANTIFUNGAL PROPHYLAXIS
PLEURISY
1
C
ANTIFUNGAL PROPHYLAXIS
PNEUMONIA
1
C
ANTIFUNGAL PROPHYLAXIS
PRURITUS
1
C
ANTIFUNGAL PROPHYLAXIS
PYREXIA
1
C
ANTIFUNGAL PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
ANTIFUNGAL PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
ANTIFUNGAL PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
ANTIFUNGAL PROPHYLAXIS
VOMITING
1
C
ANTIFUNGAL PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
ANTIVIRAL PROPHYLAXIS
ABDOMINAL DISCOMFORT
2
C
ANTIVIRAL PROPHYLAXIS
BLOOD GLUCOSE INCREASED
2
C
ANTIVIRAL PROPHYLAXIS
DIARRHOEA
2
C
ANTIVIRAL PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
ANTIVIRAL PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
ANTIVIRAL PROPHYLAXIS
EPISTAXIS
2
C
ANTIVIRAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ANTIVIRAL PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
ANTIVIRAL PROPHYLAXIS
ORAL HERPES
2
C
ANTIVIRAL PROPHYLAXIS
PLEURISY
2
C
ANTIVIRAL PROPHYLAXIS
PNEUMONIA
2
C
ANTIVIRAL PROPHYLAXIS
PRURITUS
2
C
ANTIVIRAL PROPHYLAXIS
PYREXIA
2
C
ANTIVIRAL PROPHYLAXIS
RENAL FAILURE ACUTE
2
C
ANTIVIRAL PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
2
C
ANTIVIRAL PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
2
C
ANTIVIRAL PROPHYLAXIS
VOMITING
2
C
ANTIVIRAL PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
2
C
APLASTIC ANAEMIA
ABDOMINAL DISCOMFORT
2
C
APLASTIC ANAEMIA
BLOOD GLUCOSE INCREASED
2
C
APLASTIC ANAEMIA
DIARRHOEA
2
C
APLASTIC ANAEMIA
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
APLASTIC ANAEMIA
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
APLASTIC ANAEMIA
EPISTAXIS
2
C
APLASTIC ANAEMIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
APLASTIC ANAEMIA
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
APLASTIC ANAEMIA
ORAL HERPES
2
C
APLASTIC ANAEMIA
PLEURISY
2
C
APLASTIC ANAEMIA
PNEUMONIA
2
C
APLASTIC ANAEMIA
PRURITUS
2
C
APLASTIC ANAEMIA
PYREXIA
2
C
APLASTIC ANAEMIA
RENAL FAILURE ACUTE
2
C
APLASTIC ANAEMIA
STAPHYLOCOCCAL SEPSIS
2
C
APLASTIC ANAEMIA
STEVENS-JOHNSON SYNDROME
2
C
APLASTIC ANAEMIA
VOMITING
2
C
APLASTIC ANAEMIA
WHITE BLOOD CELL COUNT DECREASED
2
C
BONE MARROW CONDITIONING REGIMEN
ABDOMINAL DISCOMFORT
6
C
BONE MARROW CONDITIONING REGIMEN
BLOOD GLUCOSE INCREASED
6
C
BONE MARROW CONDITIONING REGIMEN
DIARRHOEA
6
C
BONE MARROW CONDITIONING REGIMEN
DIFFUSE LARGE B-CELL LYMPHOMA
6
C
BONE MARROW CONDITIONING REGIMEN
DISSEMINATED INTRAVASCULAR COAGULATION
6
C
BONE MARROW CONDITIONING REGIMEN
EPISTAXIS
6
C
BONE MARROW CONDITIONING REGIMEN
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
6
C
BONE MARROW CONDITIONING REGIMEN
GRAFT VERSUS HOST DISEASE IN SKIN
6
C
BONE MARROW CONDITIONING REGIMEN
ORAL HERPES
6
C
BONE MARROW CONDITIONING REGIMEN
PLEURISY
6
C
BONE MARROW CONDITIONING REGIMEN
PNEUMONIA
6
C
BONE MARROW CONDITIONING REGIMEN
PRURITUS
6
C
BONE MARROW CONDITIONING REGIMEN
PYREXIA
6
C
BONE MARROW CONDITIONING REGIMEN
RENAL FAILURE ACUTE
6
C
BONE MARROW CONDITIONING REGIMEN
STAPHYLOCOCCAL SEPSIS
6
C
BONE MARROW CONDITIONING REGIMEN
STEVENS-JOHNSON SYNDROME
6
C
BONE MARROW CONDITIONING REGIMEN
VOMITING
6
C
BONE MARROW CONDITIONING REGIMEN
WHITE BLOOD CELL COUNT DECREASED
6
C
COLITIS ULCERATIVE
COLITIS ULCERATIVE
1
C
COLITIS ULCERATIVE
GASTROINTESTINAL HAEMORRHAGE
1
C
CONSTIPATION PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
CONSTIPATION PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
CONSTIPATION PROPHYLAXIS
DIARRHOEA
1
C
CONSTIPATION PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
CONSTIPATION PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
CONSTIPATION PROPHYLAXIS
EPISTAXIS
1
C
CONSTIPATION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
CONSTIPATION PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
CONSTIPATION PROPHYLAXIS
ORAL HERPES
1
C
CONSTIPATION PROPHYLAXIS
PLEURISY
1
C
CONSTIPATION PROPHYLAXIS
PNEUMONIA
1
C
CONSTIPATION PROPHYLAXIS
PRURITUS
1
C
CONSTIPATION PROPHYLAXIS
PYREXIA
1
C
CONSTIPATION PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
CONSTIPATION PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
CONSTIPATION PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
CONSTIPATION PROPHYLAXIS
VOMITING
1
C
CONSTIPATION PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
ENDOTRACHEAL INTUBATION
ABDOMINAL DISCOMFORT
3
C
ENDOTRACHEAL INTUBATION
BLOOD GLUCOSE INCREASED
3
C
ENDOTRACHEAL INTUBATION
DIARRHOEA
3
C
ENDOTRACHEAL INTUBATION
DIFFUSE LARGE B-CELL LYMPHOMA
3
C
ENDOTRACHEAL INTUBATION
DISSEMINATED INTRAVASCULAR COAGULATION
3
C
ENDOTRACHEAL INTUBATION
EPISTAXIS
3
C
ENDOTRACHEAL INTUBATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
3
C
ENDOTRACHEAL INTUBATION
GRAFT VERSUS HOST DISEASE IN SKIN
3
C
ENDOTRACHEAL INTUBATION
ORAL HERPES
3
C
ENDOTRACHEAL INTUBATION
PLEURISY
3
C
ENDOTRACHEAL INTUBATION
PNEUMONIA
3
C
ENDOTRACHEAL INTUBATION
PRURITUS
3
C
ENDOTRACHEAL INTUBATION
PYREXIA
3
C
ENDOTRACHEAL INTUBATION
RENAL FAILURE ACUTE
3
C
ENDOTRACHEAL INTUBATION
STAPHYLOCOCCAL SEPSIS
3
C
ENDOTRACHEAL INTUBATION
STEVENS-JOHNSON SYNDROME
3
C
ENDOTRACHEAL INTUBATION
VOMITING
3
C
ENDOTRACHEAL INTUBATION
WHITE BLOOD CELL COUNT DECREASED
3
C
GASTRITIS PROPHYLAXIS
ABDOMINAL DISCOMFORT
4
C
GASTRITIS PROPHYLAXIS
BLOOD GLUCOSE INCREASED
4
C
GASTRITIS PROPHYLAXIS
DIARRHOEA
4
C
GASTRITIS PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
4
C
GASTRITIS PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
4
C
GASTRITIS PROPHYLAXIS
EPISTAXIS
4
C
GASTRITIS PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
GASTRITIS PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
4
C
GASTRITIS PROPHYLAXIS
ORAL HERPES
4
C
GASTRITIS PROPHYLAXIS
PLEURISY
4
C
GASTRITIS PROPHYLAXIS
PNEUMONIA
4
C
GASTRITIS PROPHYLAXIS
PRURITUS
4
C
GASTRITIS PROPHYLAXIS
PYREXIA
4
C
GASTRITIS PROPHYLAXIS
RENAL FAILURE ACUTE
4
C
GASTRITIS PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
4
C
GASTRITIS PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
4
C
GASTRITIS PROPHYLAXIS
VOMITING
4
C
GASTRITIS PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
4
C
INFECTION PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
INFECTION PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
INFECTION PROPHYLAXIS
DIARRHOEA
1
C
INFECTION PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
INFECTION PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
INFECTION PROPHYLAXIS
EPISTAXIS
1
C
INFECTION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
INFECTION PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
INFECTION PROPHYLAXIS
ORAL HERPES
1
C
INFECTION PROPHYLAXIS
PLEURISY
1
C
INFECTION PROPHYLAXIS
PNEUMONIA
1
C
INFECTION PROPHYLAXIS
PRURITUS
1
C
INFECTION PROPHYLAXIS
PYREXIA
1
C
INFECTION PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
INFECTION PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
INFECTION PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
INFECTION PROPHYLAXIS
VOMITING
1
C
INFECTION PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
LOCAL ANAESTHESIA
RHABDOMYOLYSIS
1
C
PREMEDICATION
ABDOMINAL DISCOMFORT
4
C
PREMEDICATION
BLOOD GLUCOSE INCREASED
4
C
PREMEDICATION
DIARRHOEA
4
C
PREMEDICATION
DIFFUSE LARGE B-CELL LYMPHOMA
4
C
PREMEDICATION
DISSEMINATED INTRAVASCULAR COAGULATION
4
C
PREMEDICATION
EPISTAXIS
4
C
PREMEDICATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
PREMEDICATION
GRAFT VERSUS HOST DISEASE IN SKIN
4
C
PREMEDICATION
ORAL HERPES
4
C
PREMEDICATION
PLEURISY
4
C
PREMEDICATION
PNEUMONIA
4
C
PREMEDICATION
PRURITUS
4
C
PREMEDICATION
PYREXIA
4
C
PREMEDICATION
RENAL FAILURE ACUTE
4
C
PREMEDICATION
STAPHYLOCOCCAL SEPSIS
4
C
PREMEDICATION
STEVENS-JOHNSON SYNDROME
4
C
PREMEDICATION
VOMITING
4
C
PREMEDICATION
WHITE BLOOD CELL COUNT DECREASED
4
C
PRODUCT USED FOR UNKNOWN INDICATION
COLITIS ULCERATIVE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
GASTROINTESTINAL HAEMORRHAGE
1
C
PROPHYLAXIS
ABDOMINAL DISCOMFORT
8
C
PROPHYLAXIS
BLOOD GLUCOSE INCREASED
8
C
PROPHYLAXIS
DIARRHOEA
8
C
PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
8
C
PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
8
C
PROPHYLAXIS
EPISTAXIS
8
C
PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
8
C
PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
8
C
PROPHYLAXIS
ORAL HERPES
8
C
PROPHYLAXIS
PLEURISY
8
C
PROPHYLAXIS
PNEUMONIA
8
C
PROPHYLAXIS
PRURITUS
8
C
PROPHYLAXIS
PYREXIA
8
C
PROPHYLAXIS
RENAL FAILURE ACUTE
8
C
PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
8
C
PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
8
C
PROPHYLAXIS
VOMITING
8
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
8
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ABDOMINAL DISCOMFORT
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
BLOOD GLUCOSE INCREASED
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DIARRHOEA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
EPISTAXIS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ORAL HERPES
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PLEURISY
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PNEUMONIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PRURITUS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PYREXIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
RENAL FAILURE ACUTE
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
STAPHYLOCOCCAL SEPSIS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
STEVENS-JOHNSON SYNDROME
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
VOMITING
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
WHITE BLOOD CELL COUNT DECREASED
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
ABDOMINAL DISCOMFORT
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
BLOOD GLUCOSE INCREASED
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DIARRHOEA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
EPISTAXIS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
ORAL HERPES
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PLEURISY
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PNEUMONIA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PRURITUS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PYREXIA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
RENAL FAILURE ACUTE
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
STAPHYLOCOCCAL SEPSIS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
STEVENS-JOHNSON SYNDROME
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
VOMITING
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
WHITE BLOOD CELL COUNT DECREASED
2
C
RENAL IMPAIRMENT
ABDOMINAL DISCOMFORT
1
C
RENAL IMPAIRMENT
BLOOD GLUCOSE INCREASED
1
C
RENAL IMPAIRMENT
DIARRHOEA
1
C
RENAL IMPAIRMENT
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
RENAL IMPAIRMENT
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
RENAL IMPAIRMENT
EPISTAXIS
1
C
RENAL IMPAIRMENT
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
RENAL IMPAIRMENT
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
RENAL IMPAIRMENT
ORAL HERPES
1
C
RENAL IMPAIRMENT
PLEURISY
1
C
RENAL IMPAIRMENT
PNEUMONIA
1
C
RENAL IMPAIRMENT
PRURITUS
1
C
RENAL IMPAIRMENT
PYREXIA
1
C
RENAL IMPAIRMENT
RENAL FAILURE ACUTE
1
C
RENAL IMPAIRMENT
STAPHYLOCOCCAL SEPSIS
1
C
RENAL IMPAIRMENT
STEVENS-JOHNSON SYNDROME
1
C
RENAL IMPAIRMENT
VOMITING
1
C
RENAL IMPAIRMENT
WHITE BLOOD CELL COUNT DECREASED
1
C
SEDATIVE THERAPY
ABDOMINAL DISCOMFORT
2
C
SEDATIVE THERAPY
BLOOD GLUCOSE INCREASED
2
C
SEDATIVE THERAPY
DIARRHOEA
2
C
SEDATIVE THERAPY
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
SEDATIVE THERAPY
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
SEDATIVE THERAPY
EPISTAXIS
2
C
SEDATIVE THERAPY
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
SEDATIVE THERAPY
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
SEDATIVE THERAPY
ORAL HERPES
2
C
SEDATIVE THERAPY
PLEURISY
2
C
SEDATIVE THERAPY
PNEUMONIA
2
C
SEDATIVE THERAPY
PRURITUS
2
C
SEDATIVE THERAPY
PYREXIA
2
C
SEDATIVE THERAPY
RENAL FAILURE ACUTE
2
C
SEDATIVE THERAPY
STAPHYLOCOCCAL SEPSIS
2
C
SEDATIVE THERAPY
STEVENS-JOHNSON SYNDROME
2
C
SEDATIVE THERAPY
VOMITING
2
C
SEDATIVE THERAPY
WHITE BLOOD CELL COUNT DECREASED
2
Ads by Google